348 — China Healthwise Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- HK$130.21m
- HK$190.97m
- HK$113.58m
- 14
- 32
- 55
- 21
Annual cashflow statement for China Healthwise Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -72.9 | -101 | -56.4 | -132 | -40 |
| Depreciation | |||||
| Non-Cash Items | 77.9 | 127 | 45.4 | 127 | 21.9 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.7 | 11.1 | -20.7 | 13.8 | 14.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 12 | 42.1 | -28.3 | 14.5 | 3.38 |
| Capital Expenditures | -4.52 | -0.36 | -0.631 | -0.191 | -0.257 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 6.01 | 0 | — | — | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 1.5 | -0.36 | -0.631 | -0.191 | -0.257 |
| Financing Cash Flow Items | -8.48 | -7.46 | -6.97 | -7.86 | -4.52 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -25.7 | -36.4 | 5.95 | -17 | -7.84 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -12.2 | 5.18 | -23.2 | -2.43 | -4.72 |